…
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; diet whey; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -10.58M | -5.34M | -2.27M | -5.06M | -5.99M |
| Net income | -10.91M | -6.82M | -1.73M | -5.62M | -5.88M |
| Selling general administrative | 17.61M | 19.63M | 14.37M | 5.15M | 3.75M |
| Selling and marketing expenses | 17.61M | 19.63M | 14.37M | 17.53M | 10.75M |
| Gross profit | 26.94M | 31.35M | 24.60M | 22.21M | 11.96M |
| Reconciled depreciation | 4.81M | 3.63M | 3.17M | 2.77M | 0.93M |
| Ebit | -9.82M | -5.22M | -2.19M | -4.41M | -5.40M |
| Ebitda | -5.01M | -1.58M | 0.97M | -1.63M | -3.87M |
| Depreciation and amortization | 4.81M | 3.64M | 3.17M | 2.78M | 1.52M |
| Operating income | -9.82M | -5.22M | -2.19M | -4.41M | -5.40M |
| Other operating expenses | 73.59M | 67.76M | 52.59M | 54.98M | 26.71M |
| Interest expense | 0.76M | 0.12M | 0.08M | 0.02M | 1.19M |
| Tax provision | 0.33M | 1.48M | -0.55M | 0.55M | -0.12M |
| Interest income | 0.00M | 0.01M | 0.04M | 0.00M | 0.01M |
| Net interest income | -0.76M | -0.11M | -0.04M | -0.02M | 0.01M |
| Income tax expense | 0.33M | 1.48M | -0.55M | 0.55M | -0.12M |
| Total revenue | 63.77M | 62.54M | 50.35M | 50.57M | 21.32M |
| Total operating expenses | 36.76M | 36.57M | 26.83M | 26.61M | 17.35M |
| Cost of revenue | 36.84M | 31.19M | 25.75M | 28.37M | 9.36M |
| Total other income expense net | -0.76M | -0.11M | -0.08M | -0.66M | -0.59M |
| Net income from continuing ops | -10.91M | -6.82M | -1.73M | -5.62M | -5.88M |
| Net income applicable to common shares | -10.91M | -6.82M | -1.73M | -5.62M | -5.88M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 75.70M | 73.93M | 62.95M | 58.88M | 60.25M |
| Intangible assets | 13.34M | 14.32M | 14.70M | 33.07M | 16.34M |
| Other current assets | - | 12.68M | 9.84M | 10.93M | 8.94M |
| Total liab | 35.41M | 29.85M | 14.90M | 13.69M | 10.43M |
| Total stockholder equity | 40.29M | 44.07M | 48.05M | 45.20M | 49.82M |
| Deferred long term liab | 1.80M | 1.42M | 1.04M | 0.67M | 0.33M |
| Other current liab | 8.66M | 7.22M | 6.41M | 4.46M | 3.31M |
| Common stock | 17.24M | 13.51M | 13.51M | 12.28M | 12.20M |
| Capital stock | 17.24M | 13.51M | 13.51M | 12.28M | 12.20M |
| Retained earnings | -28.61M | -20.09M | -16.14M | -14.64M | -9.47M |
| Other liab | - | 2.58M | 2.19M | 2.47M | 2.46M |
| Good will | 17.40M | 17.40M | 17.40M | 17.40M | 17.40M |
| Other assets | 1.80M | 0.32M | 2.25M | 1.59M | 1.76M |
| Cash | 0.93M | 4.85M | 10.47M | 5.37M | 8.00M |
| Total current liabilities | 22.23M | 15.42M | 12.06M | 10.38M | 7.97M |
| Net debt | 20.85M | 7.56M | -9.61M | -4.29M | -8.00M |
| Short term debt | 8.59M | 0.55M | 0.21M | 0.24M | - |
| Short long term debt | 8.10M | 0.32M | - | - | - |
| Short long term debt total | 21.78M | 12.41M | 0.86M | 1.08M | - |
| Other stockholder equity | 51.66M | 50.66M | 50.68M | 47.55M | 49.22M |
| Property plant equipment | 20.87M | 15.91M | 2.37M | 2.46M | 1.03M |
| Total current assets | 24.09M | 25.98M | 27.28M | 22.44M | 24.04M |
| Net tangible assets | 9.55M | 12.36M | 16.99M | 12.80M | 16.41M |
| Net receivables | 14.99M | 12.68M | 9.10M | 9.88M | 7.95M |
| Long term debt | 2.84M | 1.18M | - | - | - |
| Inventory | 6.64M | 8.45M | 6.97M | 6.14M | 7.10M |
| Accounts payable | 4.98M | 7.64M | 5.43M | 5.68M | 4.66M |
| Accumulated other comprehensive income | - | - | - | -2.62M | -2.13M |
| Common stock total equity | - | - | 13.51M | 12.28M | 12.20M |
| Non currrent assets other | - | 31.72M | - | 36.45M | 36.20M |
| Non current assets total | 51.61M | 47.95M | 35.67M | 36.45M | 36.20M |
| Capital lease obligations | 10.84M | 10.91M | 0.86M | 1.08M | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -7.95M | -6.54M | -2.11M | -2.37M | -29.83M |
| Change to liabilities | -1.97M | 2.84M | 1.77M | 2.07M | 0.50M |
| Total cashflows from investing activities | -7.95M | -6.54M | -2.11M | -2.37M | -29.83M |
| Net borrowings | 8.81M | 1.14M | -0.15M | -0.15M | -0.15M |
| Total cash from financing activities | 12.68M | 1.08M | 4.07M | -0.18M | 27.68M |
| Net income | -10.91M | -6.82M | -1.73M | -5.62M | -5.88M |
| Change in cash | -3.92M | -5.62M | 5.09M | -2.63M | -8.57M |
| Begin period cash flow | 4.85M | 10.47M | 5.37M | 8.00M | 16.57M |
| End period cash flow | 0.93M | 4.85M | 10.47M | 5.37M | 8.00M |
| Total cash from operating activities | -8.65M | -0.16M | 3.14M | -0.08M | -6.42M |
| Issuance of capital stock | 5.00M | 0.00M | 4.54M | 0.00M | 27.92M |
| Depreciation | 4.81M | 3.63M | 3.17M | 2.77M | 0.93M |
| Change to inventory | 1.81M | -1.47M | -0.83M | 0.96M | -2.07M |
| Change to account receivables | -3.74M | -2.84M | 1.09M | -1.99M | -1.71M |
| Other cashflows from financing activities | 7.68M | 1.08M | -0.48M | -2.37M | -0.24M |
| Change to netincome | 1.35M | 4.49M | -0.32M | 1.72M | 1.81M |
| Capital expenditures | 7.95M | 6.54M | 2.11M | 2.37M | 1.46M |
| Change in working capital | -3.90M | -1.47M | 2.02M | 1.04M | -3.27M |
| Stock based compensation | 0.26M | 2.90M | 0.23M | 1.17M | 1.92M |
| Other non cash items | 0.76M | 0.11M | -0.55M | 0.55M | -0.12M |
| Free cash flow | -16.60M | -6.70M | 1.03M | -2.45M | -7.88M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ABF Associated British Foods PLC |
-39.00 1.98% |
1927.00 | 13.37 | 12.18 | 0.69 | 1.21 | 0.82 | 6.04 |
| KYGA Kerry Group |
-0.80 0.82% |
97.00 | 0.17 | 13.30 | 1.60 | 1.85 | 1.94 | 11.32 |
| MICC The Magnum Ice Cream Company N.V. |
-1.00 0.07% |
1449.00 | 25.07 | 13.30 | 0.82 | 12.11 | 1.31 | 11.19 |
| GLB Glanbia plc |
-0.80 3.85% |
20.00 | 0.28 | 12.38 | 1.08 | 2.44 | 1.36 | 13.84 |
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; diet whey; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen N. Moon | CEO & Exec. Director | NA |
| Mr. Daniel Lampard | CFO & Director | NA |
| Ms. Muna Khan | Chief Technology Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.